IJSRP Logo
International Journal of Scientific and Research Publications

IJSRP, Volume 15, Issue 7, July 2025 Edition [ISSN 2250-3153]


Epidemiological and Histopathological Trends of Meningioma: A Four-Year Retrospective Study at Sembiring General Hospital
      Suriany, Ahmad Brata Rosa
Abstract: Meningioma is the most frequently diagnosed primary tumor of the central nervous system, with higher prevalence in females and increasing incidence in older individuals. This study aimed to evaluate the clinicopathological characteristics of patients diagnosed with meningioma at Sembiring General Hospital from 2021 to 2024. A retrospective descriptive method was employed using secondary data from medical records of patients who underwent craniotomy and histopathological examination. Seventeen cases were identified during the study period. The highest number of cases was reported in 2023. Female patients constituted the majority (64.7%), with the age group of 41–50 years being the most affected. Interestingly, meningioma cases in the 61–70 age group were more commonly found in male patients. Histopathological analysis showed that the most prevalent subtype was meningothelial meningioma, and the majority of tumors were classified as WHO Grade I. Higher-grade variants, such as atypical and anaplastic meningiomas, were rare. These findings are in line with global trends, indicating a predominance of benign meningiomas in middle-aged women and a rising incidence among older men. The study provides local data that may support clinical decision-making and serve as a reference for future research on meningioma in similar settings.

Reference this Research Paper (copy & paste below code):
Suriany, Ahmad Brata Rosa (2025); Epidemiological and Histopathological Trends of Meningioma: A Four-Year Retrospective Study at Sembiring General Hospital; International Journal of Scientific and Research Publications (IJSRP) 15(7) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.15.07.2025.p16311

©️ Copyright 2011-2021 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.